Casey Shaun Hager, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4610 Kanawha Avenue, Sw, Suite 200, South Charleston, WV 25309 Phone: 304-205-7992 Fax: 304-205-7739 |
Elie G Gharib, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4610 Kanawha Ave Sw, Suite 200, South Charleston, WV 25309 Phone: 304-205-7992 Fax: 304-205-7739 |
News Archive
Administration of a tissue-cultured smallpox vaccine showed signs of an effective vaccine response with no serious adverse events, according to a study in the March 11 issue of JAMA, the Journal of the American Medical Association.
The argument that "a country's quickest way to better health for its people is economic development ... is only one factor, and not the most important one, in explaining global health outcomes," Charles Kenny, a senior fellow at the Center for Global Development, writes in a SciDev.Net opinion piece. "The challenge is to ensure that a cheap basic package of health interventions is available to - and is used by - all," he continues.
Elixir Pharmaceuticals, Inc. announced today that its partner, Siena Biotech S.p.A., has commenced Phase 1 clinical testing of Elixir's potent, first-in-class SIRT1 (sirtuin-1) inhibitor for the treatment of Huntington's Disease.
Results from a pre-specified interim analysis of a randomized, placebo-controlled Phase 3 study, COU-AA-301, demonstrate that patients treated with the investigational agent abiraterone acetate plus low-dose prednisone/prednisolone showed a significant improvement in overall survival compared to patients treated with prednisone/prednisolone plus placebo.
› Verified 9 days ago